Anti-epileptogenic Effects of Eslicarbazepine Acetate

PHASE2CompletedINTERVENTIONAL
Enrollment

129

Participants

Timeline

Start Date

May 29, 2019

Primary Completion Date

September 11, 2023

Study Completion Date

September 11, 2023

Conditions
Post Stroke Epilepsy
Interventions
DRUG

ESL 800 mg

800 mg ESL tablets for oral administration. In case a patient is unable to swallow the whole tablet, the tablet can be crushed or divided into equal doses at the score line.

DRUG

Placebo

Placebo tablets for oral administration, matching the test product. In case a patient is unable to swallow the whole tablet, the tablet can be crushed or divided into equal doses at the score line.

Trial Locations (22)

4020

Kepler University Hospital GmbH, Neuromed Campus, Department of Neurology 1, Linz

4021

Kepler University Hospital, Med Campus III, Department of Neurology 2, Linz

5050

Clinical Research Center Salzburg GmbH, Salzburg

6020

Medizinische Universität Innsbruck, Universitätsklinik für Neurologie, Innsbruck

9020

Klinikum am Wörthersee, Abteilung fur Neurologie, Klagenfurt

28040

Hospital Universitario Fundación Jiménez Diaz, Madrid

33100

Clinica Neurologica e di Neuroriabllltazione - Azienda / Ospedallero-Universitarla S. Maria della Miserrcordia, Udine

34149

Azienda Sanitaria Universitaria Integrata di Trieste - Ospedale Cattinara - Clinica Neurologica, Trieste

35043

UKGM Universitatsklinikum Marburg, Klinik und Poliklinik fur Neurologie, Marburg

39012

Azienda Sanitaria dell'Alto Adige - Ospedale di Merano, Merano

41345

Sahlgrenska universitetssjukhuset, Neurosjukvarden, Gothenburg

45147

Universitatsklinikum Essen, Klinik fur Neurologie, Essen

52074

Uniklinik RWTH Aachen, Klinik für Neurologie, Aachen

64239

Tel Aviv Sourasky Medical Center, Neurology Division, Tel Aviv

69677

Hospices Civils de Lyon, Neurological Hospitals, Bron

72076

Neurologische Universitatsklinik, Tübingen

81377

LMU Ludwig-Maximilians-Universitat, Munchen, Klinikum Grobhadern, Neurologische Klinik und Poliklinik, Experimentelle Neurologie, München

91054

Universitatsklinikum Erlangen, Neurologische Klinik, Erlangen

5265601

Sheba Medical Center, Neurology Department, Stroke Unit, Ramat Gan

1649-035

Centro Hospitalar Universitário Lisboa Norte, E.P.E. - Hospital Santa Maria - Serviço de Neurologia, Lisbon

SE5 9RS

King's College Hospital, London

WC1N 3BG

Institute of Neurology, London

All Listed Sponsors
lead

Bial - Portela C S.A.

INDUSTRY

NCT06597084 - Anti-epileptogenic Effects of Eslicarbazepine Acetate | Biotech Hunter | Biotech Hunter